Literature DB >> 12406685

Rapid refolding and polishing of single-chain antibodies from Escherichia coli inclusion bodies.

Jessica R Sinacola1, Anne S Robinson.   

Abstract

An inexpensive and fast-folding strategy for single-chain antibody (scFv) recovered from Escherichia coli inclusion bodies has been developed. Two anti-fluorescein single-chain antibodies, 4-4-20 and 4M5.3, were expressed as inclusion bodies in E. coli for use in a comparative refolding study. Active protein yields as well as degree of aggregation were evaluated for scFv produced by stepwise dialysis, redox dialysis, and a newly developed controlled dilution and filtration strategy. Although all three methods produced active protein for both 4-4-20 and 4M5.3, the extent of aggregation differed greatly among the methods. For 4-4-20, the controlled dilution and filtration strategy reduced aggregation by half, allowed batch processing times of 8h (an 18-fold improvement), and significantly reduced denaturant usage while increasing active yields by 150%. A hydroxyapatite resin polishing step was used to remove completely the aggregate species and inactive monomeric scFv from active scFv.

Entities:  

Mesh:

Year:  2002        PMID: 12406685     DOI: 10.1016/s1046-5928(02)00538-7

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  6 in total

1.  Preparation of biologically active single-chain variable antibody fragments that target the HIV-1 gp120 V3 loop.

Authors:  Y T Ong; K A Kirby; A Hachiya; L A Chiang; B Marchand; K Yoshimura; T Murakami; K Singh; S Matsushita; S G Sarafianos
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  2012-12-22       Impact factor: 1.770

2.  Biophysical characterization and molecular simulation of electrostatically driven self-association of a single-chain antibody.

Authors:  Christopher J O'Brien; Cesar Calero-Rubio; Vladimir I Razinkov; Anne S Robinson; Christopher J Roberts
Journal:  Protein Sci       Date:  2018-05-03       Impact factor: 6.725

3.  Specificity of furanoside-protein recognition through antibody engineering and molecular modeling.

Authors:  Parnian Lak; Spandana Makeneni; Robert J Woods; Todd L Lowary
Journal:  Chemistry       Date:  2014-11-20       Impact factor: 5.236

4.  Use of the amicyanin signal sequence for efficient periplasmic expression in E. coli of a human antibody light chain variable domain.

Authors:  Brian A Dow; Suren A Tatulian; Victor L Davidson
Journal:  Protein Expr Purif       Date:  2015-01-05       Impact factor: 1.650

5.  High-level secretion of recombinant monomeric murine and human single-chain Fv antibodies from Drosophila S2 cells.

Authors:  Allissia A Gilmartin; Benjamin Lamp; Till Rümenapf; Mats A A Persson; Félix A Rey; Thomas Krey
Journal:  Protein Eng Des Sel       Date:  2011-12-12       Impact factor: 1.650

6.  Expression and Evaluation of HuscFv Antibody -PE40 Immunotoxin for Target Therapy of EGFR-Overexpressing Cancers.

Authors:  Dianoush Falahatgar; Safar Farajnia; Nosratollah Zarghami; Asghar Tanomand; Shiva Ahdi Khosroshahi; Bahman Akbari; Hadi Farajnia
Journal:  Iran J Biotechnol       Date:  2018-12-12       Impact factor: 1.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.